Back to search

Article

Influence of CYP2C19 and ABCB1 Genetic Polymorphisms on Clopidogrel Pharmacokinetics: A PharmGKB Retrospective Analysis

2025-07-07

Abstract excerpt

<h4>Background: </h4> Clopidogrel, an antiplatelet prodrug widely prescribed for thrombotic risk reduction in cardiovascular patients, shows marked interindividual response variability due to genetic polymorphisms in CYP2C19 and ABCB1. <h4>Objectives:</h4> To determine the impact of key polymorphisms (CYP2C19 *2, *3 and ABCB1 3435C&gt;T) on pharmacokinetic parameters and adherence outcomes, using curated PharmGKB...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
71d1265b-86ae-5ceb-af6e-aa9c75dad494
DOI
10.20944/preprints202507.0576.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Influence of CYP2C19 and ABCB1 Genetic Polymorphisms on Clopidogrel Pharmacokinetics: A PharmGKB Retrospective AnalysisDOI 10.20944/preprints202507.0576.v1
Select a neighboring publication to make it the new centre.